Allgenesis Biotherapeutics v. Cloudbreak Therapeutics — Federal Circuit Dismisses IPR Appeal for Lack of Article III Standing
The Federal Circuit dismissed Allgenesis’s appeal from an adverse IPR decision for lack of Article III standing, holding that vague future product plans and non-appealable priority rulings do not constitute a concrete injury sufficient to invoke federal court jurisdiction.